Insider trade

Attovia Therapeutics (ATTO): CEO received 538K units

Tao Fu, CEO at Attovia Therapeutics, reported a grant / award of 538K units.

538K
Derivative units
Traded
Aug 4, 2026
Filed
Oct 9, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

    What came next

    1. Aug 6, 2026Company filing · Form 8-K · Bylaws or charterChanged its bylaws, charter or fiscal year
    2. Sep 2, 2026Company filing · Form 8-K · ResultsReported its results
    3. Nov 9, 2026Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
    4. Nov 13, 20265% stakeAlamar HoldCo, LLC reported a passive stake (13G) of 7.1%
    5. Nov 13, 20265% stakeGOLDMAN SACHS GROUP INC reported a passive stake (13G) of 6.7%
    6. Nov 16, 20265% stakevenBio Global Strategic Fund IV, L.P. reported a passive stake (13G) of 9.2%
    View the official recordSEC Form 4

    How to read SEC Form 4

    Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

    Full guide: What is an SEC Form 4?

    What else is on file for Attovia Therapeutics

    For Attovia Therapeutics, OQRO holds 3 fund holdings reports (13F) dated in the last 90 days.

    These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ATTO page.

    How this filing works

    Explore the data

    Common questions

    Which Attovia Therapeutics (ATTO) insider traded, and how much?

    Tao Fu, CEO at Attovia Therapeutics, reported a grant / award of 538K units. Not an open-market trade.

    When did it happen, and when was it made public?

    Traded: Aug 4, 2026. Filed: Oct 9, 2026. That is 66 days between the two dates.

    Is the dollar amount exact?

    It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

    Where does this information come from?

    From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

    What else has been disclosed about Attovia Therapeutics recently?

    For Attovia Therapeutics, OQRO holds 3 fund holdings reports (13F) dated in the last 90 days. They are listed on the ATTO page.

    Does this mean ATTO stock is a buy or a sell?

    No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

    Is OQRO free?

    Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

    Other disclosures at Attovia Therapeutics

    Everything OQRO holds on this company is on its ATTO page.

    This is one filing. OQRO holds the rest

    Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

    OQRO is free for everyone. No card, no trial

    OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data